Hansa Biopharma Balance Sheet Health
Financial Health criteria checks 1/6
Hansa Biopharma has a total shareholder equity of SEK-218.8M and total debt of SEK956.4M, which brings its debt-to-equity ratio to -437.1%. Its total assets and total liabilities are SEK1.0B and SEK1.2B respectively.
Key information
-437.1%
Debt to equity ratio
SEK 956.35m
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 705.00m |
| Equity | -SEK 218.79m |
| Total liabilities | SEK 1.25b |
| Total assets | SEK 1.03b |
Recent financial health updates
Does Hansa Biopharma (STO:HNSA) Have A Healthy Balance Sheet?
Sep 22
Rock star Growth Puts Hansa Biopharma (STO:HNSA) In A Position To Use Debt
Apr 03Recent updates
Hansa Biopharma AB (publ) (STO:HNSA) Analysts Just Slashed This Year's Revenue Estimates By 11%
Jul 23Hansa Biopharma AB (publ) (STO:HNSA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Jul 21Shareholders May Be Wary Of Increasing Hansa Biopharma AB (publ)'s (STO:HNSA) CEO Compensation Package
Jun 21Hansa Biopharma AB (publ) (STO:HNSA) Looks Just Right With A 32% Price Jump
May 21Some Analysts Just Cut Their Hansa Biopharma AB (publ) (STO:HNSA) Estimates
Apr 05Analyst Estimates: Here's What Brokers Think Of Hansa Biopharma AB (publ) (STO:HNSA) After Its Yearly Report
Feb 07Hansa Biopharma AB (publ) (STO:HNSA) Not Lagging Industry On Growth Or Pricing
Dec 28Newsflash: Hansa Biopharma AB (publ) (STO:HNSA) Analysts Have Been Trimming Their Revenue Forecasts
Oct 13Does Hansa Biopharma (STO:HNSA) Have A Healthy Balance Sheet?
Sep 22Investors Holding Back On Hansa Biopharma AB (publ) (STO:HNSA)
May 31Rock star Growth Puts Hansa Biopharma (STO:HNSA) In A Position To Use Debt
Apr 03Hansa Biopharma AB (publ) (STO:HNSA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Feb 06Need To Know: The Consensus Just Cut Its Hansa Biopharma AB (publ) (STO:HNSA) Estimates For 2023
Feb 01Financial Position Analysis
Short Term Liabilities: HNSA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: HNSA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: HNSA has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: HNSA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HNSA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: HNSA has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 21.9% each year.